Literature DB >> 17911166

Genetics of sporadic amyotrophic lateral sclerosis.

J C Schymick1, K Talbot, B J Traynor.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized clinically by rapidly progressive paralysis leading ultimately to death from respiratory failure. There is substantial evidence suggesting that ALS is a heritable disease, and a number of genes have been identified as being causative in familial ALS. In contrast, the genetics of the much commoner sporadic form of the disease is poorly understood and no single gene has been definitively shown to increase the risk of developing ALS. In this review, we discuss the genetic evidence for each candidate gene that has been putatively associated with increased risk of sporadic ALS. We also review whole genome association studies of ALS and discuss the potential of this methodology for identifying genes relevant to motor neuron degeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17911166     DOI: 10.1093/hmg/ddm215

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  62 in total

Review 1.  Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis.

Authors:  Lee J Martin; Qing Chang
Journal:  Mol Neurobiol       Date:  2011-11-10       Impact factor: 5.590

2.  Advances in the application of MRI to amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Michel Modo
Journal:  Expert Opin Med Diagn       Date:  2010-11

Review 3.  Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis.

Authors:  Lee J Martin
Journal:  IDrugs       Date:  2010-08

4.  Human angiogenin presents neuroprotective and migration effects in neuroblastoma cells.

Authors:  Goang-Won Cho; Byung Yong Kang; Seung Hyun Kim
Journal:  Mol Cell Biochem       Date:  2010-02-20       Impact factor: 3.396

Review 5.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

6.  Familial risks for amyotrophic lateral sclerosis and autoimmune diseases.

Authors:  Kari Hemminki; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Neurogenetics       Date:  2008-12-17       Impact factor: 2.660

7.  Prospective study of chemical exposures and amyotrophic lateral sclerosis.

Authors:  M G Weisskopf; N Morozova; E J O'Reilly; M L McCullough; E E Calle; M J Thun; A Ascherio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-05       Impact factor: 10.154

8.  Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS.

Authors:  Clement Y Chow; John E Landers; Sarah K Bergren; Peter C Sapp; Adrienne E Grant; Julie M Jones; Lesley Everett; Guy M Lenk; Diane M McKenna-Yasek; Lois S Weisman; Denise Figlewicz; Robert H Brown; Miriam H Meisler
Journal:  Am J Hum Genet       Date:  2009-01       Impact factor: 11.025

9.  Genome-wide association studies in amyotrophic lateral sclerosis.

Authors:  Nicolas Dupré; Paul Valdmanis
Journal:  Eur J Hum Genet       Date:  2008-11-05       Impact factor: 4.246

10.  Screening for replication of genome-wide SNP associations in sporadic ALS.

Authors:  Simon Cronin; Barbara Tomik; Daniel G Bradley; Agnieszka Slowik; Orla Hardiman
Journal:  Eur J Hum Genet       Date:  2008-11-05       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.